Skip to main content
OpenTrials
Completed

NCT Number: NCT01151241

Early Discharge in Patients Undergoing Elbow Arthroscopy

Patients undergoing elbow arthroscopy surgery will receive standard anesthesia and analgesia (infraclavicular nerve block combined with general anesthesia for surgery; continuous infusion via infraclavicular catheter to day 3 post op). Patients in the experimental group will be discharged home after one day, with infraclavicular catheter in place; patients in the comparator group will stay in hospital for 3 or 4 days, per standard practice. The study will compare range of motion as the primary endpoint, in a non-inferiority design, to see if early discharge is feasible while providing similar recovery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elbow Arthroscopy Surgery

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing elective complex arthroscopic elbow surgery requiring postoperative CPM - synovectomy, capsulectomy, extensive debridement, contracture release, osteocapsular arthroplasty.
  • ASA I-III

Exclusion criteria

  • Age>65
  • Cognitively challenged patients
  • Severe COPD
  • Patients who, on their own or with the assistance of a caregiver, are not confident of being able to remove the local anesthetic infusion catheter at home
  • Psychiatric history
  • Allergy to ropivacaine.
  • Opioid tolerance (>60mg oral morphine or equivalent/day)

Treatment and study plan

Elbow arthroscopy with infraclavicular nerve block and continuous local anesthetic infusion to day 3 post op.

Procedure

Patients undergoing elbow arthroscopy surgery will receive standard anesthesia/analgesia, including infraclavicular nerve block and general anesthesia for surgery followed by infraclavicular catheter infusion of local anesthetic until day 3 after surgery.

Early Discharge

Other

Patients will be discharged home on the first day after surgery, with infraclavicular catheter infusion of local anesthetic in place.

Normal Discharge

Other

Patients will remain in hospital and be discharged per current discharge criteria, once the infraclavicular catheter has been removed on day 3 post op. Typical discharge occurs on day 3 or 4 post op.

Primary outcomes

  1. Range of Motion

    Time frame: 1 year

    Range of motion at the elbow will be measured vs. baseline to determine surgical success.

Secondary outcomes

  1. Post-operative analgesia

    Time frame: 3 days

    Pain scores, by visual analogue scale, will be used to determine patient satisfaction with analgesia to day 3 after surgery.

Sponsors and collaborators

Lead sponsor

University Health Network, Toronto

Other

Registry information

Official study title

Outpatient Versus Inpatient Continuous Brachial Plexus Block for Complex Arthroscopic Elbow Surgery: Safety and Functional Outcome

Important dates

Study start
2010
Primary completion
2014
Study completion
2014
First posted
Jun 28, 2010
Registry last updated
Feb 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.